These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 30150059)

  • 61. HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis.
    Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
    Biochem Biophys Res Commun; 2018 Nov; 506(1):189-193. PubMed ID: 30342849
    [TBL] [Abstract][Full Text] [Related]  

  • 62. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/β-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-β catenin-p300 Interactions in Hepatocellular Carcinoma.
    Leung YK; Lee SG; Wang J; Guruvaiah P; Rusch NJ; Ho SM; Park C; Kim K
    Adv Sci (Weinh); 2024 Aug; 11(29):e2308539. PubMed ID: 38790135
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 66. EZH2 suppresses ferroptosis in hepatocellular carcinoma and reduces sorafenib sensitivity through epigenetic regulation of TFR2.
    Lai Y; Han X; Xie B; Xu Y; Yang Z; Wang D; Li W; Xie Y; Song W; Zhang X; Xia JQ; Zhang P
    Cancer Sci; 2024 Jul; 115(7):2220-2234. PubMed ID: 38623968
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.
    Wang Y; Wang M; Wei W; Han D; Chen X; Hu Q; Yu T; Liu N; You Y; Zhang J
    Oncotarget; 2016 Aug; 7(31):49450-49458. PubMed ID: 27385092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. YTHDF3-mediated m6A modification of NKD1 regulates hepatocellular carcinoma invasion and metastasis by activating the WNT/β-catenin signaling axis.
    Chen S; Wang L; Xu Z; Chen L; Li Q; Zhong F; Tang N; Song J; Zhou R
    Exp Cell Res; 2024 Sep; 442(1):114192. PubMed ID: 39127439
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma.
    Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL
    BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular Carcinoma.
    Xu F; Li CH; Wong CH; Chen GG; Lai PBS; Shao S; Chan SL; Chen Y
    Cancer Res; 2019 Apr; 79(7):1305-1317. PubMed ID: 30718359
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating Wnt signal through forming T-cell factor-4/Beta-catenin/FOXG1 complex.
    Zheng X; Lin J; Wu H; Mo Z; Lian Y; Wang P; Hu Z; Gao Z; Peng L; Xie C
    J Exp Clin Cancer Res; 2019 Nov; 38(1):475. PubMed ID: 31771611
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor.
    Hu J; Zhang J; Sun F; Qi M; Su P; Liu H; Gao L; Jiao M; Wu Z; Xiang L; Han B
    Anticancer Drugs; 2019 Aug; 30(7):e0746. PubMed ID: 31305292
    [TBL] [Abstract][Full Text] [Related]  

  • 73. EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.
    Lian R; Ma H; Wu Z; Zhang G; Jiao L; Miao W; Jin Q; Li R; Chen P; Shi H; Yu W
    Mol Cell Biochem; 2018 Feb; 439(1-2):35-43. PubMed ID: 28795320
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CCN6 Suppresses Metaplastic Breast Carcinoma by Antagonizing Wnt/β-Catenin Signaling to Inhibit EZH2-Driven EMT.
    Gonzalez ME; Brophy B; Eido A; Leonetti AE; Djomehri SI; Augimeri G; Carruthers NJ; Cavalcante RG; Giordano F; Andò S; Nesvizhskii AI; Fearon ER; Kleer CG
    Cancer Res; 2024 Oct; 84(19):3235-3249. PubMed ID: 39024552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H
    Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.
    Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y
    Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator.
    Kim J; Lee Y; Lu X; Song B; Fong KW; Cao Q; Licht JD; Zhao JC; Yu J
    Cell Rep; 2018 Dec; 25(10):2808-2820.e4. PubMed ID: 30517868
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
    Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H
    Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma.
    Zhang L; Li HT; Shereda R; Lu Q; Weisenberger DJ; O'Connell C; Machida K; An W; Lenz HJ; El-Khoueiry A; Jones PA; Liu M; Liang G
    Cancer Lett; 2022 Nov; 548():215899. PubMed ID: 36087682
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC.
    Zeng B; Lin Z; Ye H; Cheng D; Zhang G; Zhou J; Huang Z; Wang M; Cai C; Zeng J; Tang C; Liu J
    Cell Physiol Biochem; 2018; 46(3):1122-1133. PubMed ID: 29669339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.